180 related articles for article (PubMed ID: 16263301)
1. The development of 3D-QSAR study and recursive partitioning of heterocyclic quinone derivatives with antifungal activity.
Choi SY; Shin JH; Ryu CK; Nam KY; No KT; Park Choo HY
Bioorg Med Chem; 2006 Mar; 14(5):1608-17. PubMed ID: 16263301
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment.
Ryu CK; Lee Y; Park SG; You HJ; Lee RY; Lee SY; Choi S
Bioorg Med Chem; 2008 Nov; 16(22):9772-9. PubMed ID: 18930405
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity relationship studies for prediction of antimicrobial activity of synthesized 2,4-hexadienoic acid derivatives.
Narasimhan B; Judge V; Narang R; Ohlan R; Ohlan S
Bioorg Med Chem Lett; 2007 Nov; 17(21):5836-45. PubMed ID: 17869511
[TBL] [Abstract][Full Text] [Related]
4. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
5. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling of azole antifungal agents active against Candida albicans. 1. A comparative molecular field analysis study.
Tafi A; Anastassopoulou J; Theophanides T; Botta M; Corelli F; Massa S; Artico M; Costi R; Di Santo R; Ragno R
J Med Chem; 1996 Mar; 39(6):1227-35. PubMed ID: 8632429
[TBL] [Abstract][Full Text] [Related]
7. Artificial neural networks in prediction of antifungal activity of a series of pyridine derivatives against Candida albicans.
Buciński A; Socha A; Wnuk M; Baczek T; Nowaczyk A; Krysiński J; Goryński K; Koba M
J Microbiol Methods; 2009 Jan; 76(1):25-9. PubMed ID: 18824043
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity, mechanism and QSAR studies on chalcones.
Sivakumar PM; Muthu Kumar T; Doble M
Chem Biol Drug Des; 2009 Jul; 74(1):68-79. PubMed ID: 19519746
[TBL] [Abstract][Full Text] [Related]
9. QSAR analysis for heterocyclic antifungals.
Duchowicz PR; Vitale MG; Castro EA; Fernández M; Caballero J
Bioorg Med Chem; 2007 Apr; 15(7):2680-9. PubMed ID: 17296301
[TBL] [Abstract][Full Text] [Related]
10. QSAR study of antimicrobial activity of some 3-nitrocoumarins and related compounds.
Debeljak Z; Skrbo A; Jasprica I; Mornar A; Plecko V; Banjanac M; Medić-Sarić M
J Chem Inf Model; 2007; 47(3):918-26. PubMed ID: 17489552
[TBL] [Abstract][Full Text] [Related]
11. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
[TBL] [Abstract][Full Text] [Related]
12. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
Puntambekar DS; Giridhar R; Yadav MR
Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
[TBL] [Abstract][Full Text] [Related]
14. QSAR modeling of the antifungal activity against Candida albicans for a diverse set of organic compounds.
Katritzky AR; Slavov SH; Dobchev DA; Karelson M
Bioorg Med Chem; 2008 Jul; 16(14):7055-69. PubMed ID: 18550376
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.
Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R
Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233
[TBL] [Abstract][Full Text] [Related]
16. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
Roy KK; Dixit A; Saxena AK
J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
Puntambekar D; Giridhar R; Yadav MR
Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antifungal activity of 2/3-arylthio- and 2,3-bis(arylthio)-5-hydroxy-/5-methoxy-1,4-naphthoquinones.
Ryu CK; Shim JY; Chae MJ; Choi IH; Han JY; Jung OJ; Lee JY; Jeong SH
Eur J Med Chem; 2005 May; 40(5):438-44. PubMed ID: 15893017
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
Akula N; Lecanu L; Greeson J; Papadopoulos V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
